latest news releases from the newsroom
Astex, The Wellcome Trust, The Institute of Cancer Research and Cancer Research Technology Announce Major Cancer Drug Discovery Collaboration
CAMBRIDGE, U.K., March 22, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery company, together with The Wellcome Trust, the Institute of Cancer Research and Cancer Research Technology today announced an exclusive collaboration relating to the discovery of novel drugs against the cancer target BRAF. BRAF was first identified as a key target implicated in a variety of cancers in 2002 when scientists from The Institute of Cancer Research, in partnership with scientists from the Cancer Genome Project at The Wellcome Trust Sanger Institute in Cambridge, discovered that the gene is involved in up to 70% of certain cancer types including malignant melanoma.
Sampo Commences Financing Arrangements For IF Transaction
STOCKHOLM, Sweden, March 22, 2004 (PRIMEZONE) -- The Board of Directors of Sampo plc has today decided to launch on the international capital markets a EUR 600 million callable subordinated notes, eligible for inclusion in the capital adequacy calculation. Sampo seeks listing of the above notes for public trading in the London Stock Exchange.
DigiLava Extends Dial-Up Contract and Partner with PurespeedPlus
SAN FRANCISCO, March 19, 2004 (PRIMEZONE) -- DigiLava, Inc. (Pink Sheets:DGLV) today announced it has signed a new contract with PurespeedPlus, one of the nation's leading virtual dial access providers, that will continue to make PurespeedPlus the exclusive provider of wholesale dial-up services to the San Francisco-based ASP and BSP through mid-2005.